United States · FDA National Drug Code directory

Cisplatin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
25021-253_bf489cd3-17a3-4398-ba7e-2cb9e87b9c13
Product NDC
25021-253
Form
INJECTION, SOLUTION
Composition / generic term
Cisplatin
Labeler
Sagent Pharmaceuticals
Marketing category
ANDA
Marketing start / end (source format)
20230701
Source listing expiry
20261231

Source-listed ingredients

  • CISPLATIN — 1 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 VIAL in 1 CARTON (25021-253-50) / 50 mL in 1 VIAL · 25021-253-50
  • 1 VIAL in 1 CARTON (25021-253-51) / 100 mL in 1 VIAL · 25021-253-51

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Cisplatin — United States | Molindra Medicines